News and Events

Connecting with Industry Leaders: Our Journey at ASAIO 2023

August 21, 2023
On the heels of the FDA approval of the new software updates for the Freedom Driver, SynCardia was out in force at the 2023 Annual Conference of the American Society of Artificial Internal Organs (ASAIO)

Altitude Acquisition Corp. files preliminary proxy statement with SEC for merger with Picard Medical, Inc. and its subsidiary, SynCardia Systems LLC

August 14, 2023
A preliminary proxy statement has been filed with the Securities and Exchange Commission by Altitude Acquisition Corp. for its proposed merger with Picard Medical, Inc and SynCardia Systems LLC.

Showcased our virtual tour at the Heart Hackathon.

August 1, 2023
As a platinum sponsor of the HeartHackathon, Tucson, Arizona-based SynCardia is demonstrating its commitment to education, innovation, and to advancing the field of artificial heart technologies.

SynCardia Updates Total Artificial Heart Labeling with Real World Data

July 11, 2023
SynCardia Systems, LLC., a Picard Medical Company, today announced that the U.S. Food and Drug Administration (FDA) has approved an update of the SynCardia TAH-t label with real world data further confirming the safety and performance of the Companion 2 Driver.

Randy’s Remarkable Journey: Celebrating the 10-Year Anniversary Since Receiving SynCardia’s Totally Artificial Heart

July 7, 2023
Celebrating Randy’s incredible 10-year anniversary since receiving a Total Artificial Heart! Despite facing immense challenges, Randy has shown us what it means to live life to the fullest and embrace every opportunity with unwavering determination.

SynCardia Welcomes Patrick NJ Schnegelsberg as CEO

June 28, 2023
We are excited about the announcement that Patrick NJ Schnegelsberg is the new Chief Executive Officer of SynCardia Systems, LLC the parent company of Picard Medical, Inc. A global leader in mechanical heart replacement technology.
loading more...